This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Tracking COVID-19 in Pregnant Women and Infants


Highlights

  • CDC needs data rapidly on COVID-19 effects on pregnant women.
  • Abt’s existing infrastructure will track COVID-19 during pregnancy and infancy.
  • Results are ongoing and constantly evolving with the pandemic.
The Challenge

Pregnant women may be more vulnerable than the general population to respiratory infections and severe respiratory complications from COVID-19, and CDC needs more research on their potential effects on birth outcomes to guide the public. In particular, CDC needs timely information on the risk factors for infection, characteristics of COVID-19 illness and complications, and the effects of infection on pregnancy and infant outcomes. A better understanding may help inform future public health COVID-19 policy for pregnant women and infants.

The Approach

Abt is using an existing network of sites and protocols from CDC Pandemic Flu and Global Flu contracts to study COVID-19 in pregnant women. The studies include a retrospective electronic medical record review of women seeking prenatal care and a community-based cohort seeking prenatal care at participating clinics followed throughout pregnancy. We will identify COVID-19 (and vaccine) knowledge, attitudes, and beliefs, pregnancy/infant outcomes, and potential COVID-19 cases. The data can improve modelling of respiratory illness burden and characteristics during pregnancy.

The Results

Results are ongoing.